Cesarean section in the second delivery to prevent anal incontinence after asymptomatic obstetrical anal sphincter injury: the EPIC multicenter randomized trial
Laurent Abramowitz(Université Paris Cité), Florence Tubach(Inserm), Olivier Poujade(Hôpital Beaujon), Celine De Carn Carnavalet, Agnès Bourgeois Moine, A. Le Tohic(Centre Hospitalier de Versailles), Carine Roy(Lyon 1 Université), Laurent Mandelbrot(Hôpital Cochin)
Cited by 0
Related Papers
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
|The Lancet|1999|667
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|Cochrane Database of Systematic Reviews|2017|648
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry
|Arthritis & Rheumatism|2009|631
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
|The Lancet Infectious Diseases|2017|473
Are sphincter defects the cause of anal incontinence after vaginal delivery?
|Diseases of the Colon & Rectum|2000|223